Ngā hua rapu - Carpentier, C
- E whakaatu ana i te 1 - 8 hua o te 8
-
1
-
2
P06.19 TERT promoter mutation is an independent prognostic factor in 1p/19q co-deleted oligodendrogliomas: a POLA network study mā Alentorn, A., Carpentier, C., Labreche, K., Ducray, F., Dehais, C., Mokhtari, K., Uro-Coste, E., Figarella-Branger, D., Delattre, J., Idbaih, A.
I whakaputaina 2016Text -
3
Émergence de variants E484 K suite à une monothérapie bamlanivimab chez des patients COVID-19 à haut risque d’évolution vers une forme sévère mā Peiffer-Smadja, N., Bridier-Nahmias, A., Carpentier, C., Garé, M., Rioux, C., Allemand, A., Kramer, L., Descamps, D., Yazdanpanah, Y., Visseaux, B.
I whakaputaina 2021Text -
4
O10.02 MITOTIC INDEX, MICROVASCULAR PROLIFERATION AND NECROSIS DEFINE THREE GROUPS OF 1P/19Q CO-DELETED ANAPLASTIC OLIGODENDROGLIOMAS ASSOCIATED WITH DIFFERENT GENOMIC ALTERATIONS mā Figarella-Branger, D., Mokhtari, K., Dehais, C., Jouvet, A., Uro-Coste, E., Colin, C., Carpentier, C., Ducray, F., Idbaih, A., Network, French POLA
I whakaputaina 2014Text -
5
P17.01 CHROMOSOME ARM 9P LOSS OF HETEROZYGOSITY IS A MARKER OF SHORTER SURVIVAL IN 1P/19Q CO-DELETED ANAPLASTIC OLIGODENDROGLIOMA. A POLA NETWORK STUDY mā Alentorn, A., Dehais, C., Carpentier, C., Mokhtari, K., Ducray, F., Figarella-Branger, D., Delattre, J., Idbaih, A., (POLA)”, POLA Network “Prise en charge des OLigodendrogliomes Anaplasiques
I whakaputaina 2014Text -
6
PL1.1 CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDHmutant gliomas mā Appay, R, Dehais, C, Colin, C, Alentorn, A, Carpentier, C, Ducray, F, Ibdaih, A, Kamoun, A, Mokhtari, K, Tabouret, E, Uro-Coste, E, Delattre, J, Figarella-Branger, D
I whakaputaina 2019Text -
7
OS9.2 Radiomics analysis of lower-grade gliomas, a POLA Network study mā Younan, N, Douzane, H, Duran-Pena, A, Nichelli, L, Garcilazo, Y, Dehais, C, Ducray, F, Carpentier, C, Mokhtari, K, Figarella-Branger, D, Delattre, J, Idbaih, A, Alentorn, A
I whakaputaina 2019Text -
8
P04.12 Characteristics of IDH-mutant gliomas with non-canonical IDH mutations mā Poetsch, L, Dehais, C, Frénel, J, Siegfried, A, Lacomme, S, Seizeur, R, Larrieu-Ciron, D, Cappellen, D, Loussouarn, D, Ferec, C, Eimer, S, Carpentier, C, Sanson, M, Delattre, J, Figarella-Branger, D, Ducray, F, Bronnimann, C
I whakaputaina 2019Text